UNSPSC 51161551: Perbufylline

This classification denotes a phosphodiesterase inhibitor and bronchodilator, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier M69H5TDQ1K. European Medicines Agency schedules Perbufylline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09717MIG. Perbufylline generally arises in the molecular formula C23H28FN5O3.

UNSPSC 51161551 Perbufylline (Commodity) encompasses pharmaceutical products that state and local government health systems procure through cooperative purchasing alliances and group purchasing agreements. The solicitations under this code reflect procurement of brand-name and generic pharmaceuticals distributed through authorized wholesaler networks to state agencies, local health departments, and participating institutional buyers. The work involves manufacturers or authorized distributors supplying finished pharmaceutical products with specific National Drug Codes and packaging configurations, meeting current Good Manufacturing Practices (cGMP) and Drug Supply Chain Security Act (DSCSA) compliance requirements, and maintaining contractual relationships with primary wholesale logistics partners.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP on January 20, 2026 (due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and over-the-counter products distributed across participating state and local government facilities in Minnesota, Oregon, and other member states. MMCAP requires vendors to supply products through three authorized wholesalers—AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC—with awarded vendors taking effect July 1, 2026. Evaluation weightings emphasize price competitiveness (75 percent), fixed pricing (10 percent), and compliance with administrative requirements and EDI capability (5 percent each); vendors must maintain $5,000,000 in commercial general liability coverage and $2,000,000 in network security and professional liability insurance, with contract terms of two years for new responders and optional extensions. Specific dollar values or total procurement budgets are not disclosed in the RFP documentation.